© Copyright 2012, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
He called the results late last week: "The Bills are going to be 4 and 1 after Sunday. I think they can take the Eagles, and I'm looking forward to it. I think they have a chance to do really well this year. That was Michael J. Fox, movie star and, apparently, astute football fan.
DANVILLE, Calif., Sept. 9 /PRNewswire-USNewswire/ -- The Danville d'Elegance Foundation is joining forces with The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Parkinson's Institute (PI) to host a gala event and car show to support the fight against Parkinson's disease. The annual festivities, official Team Fox events that will be held in Danville, California, will begin with a ticketed evening gala and live auction on Saturday, September 18. A public car show, Danville Concours d'Elegance, featuring some of the world's finest automobiles will be held the following day. Proceeds from auction items and ticket sales as well as donations to the free car show will benefit both MJFF and PI. The Danville d'Elegance Foundation is an incredible example of what a small but ...
-Denny's events kick off in New York to support Parkinson's disease research- NEW YORK, April 30 /PRNewswire-USNewswire/ -- Denny's franchisees Glenn and Tina Beattie are joining the fight against Parkinson's disease by hosting a pancake event to benefit Team Fox, the grassroots fundraising arm of The Michael J. Fox Foundation for Parkinson's Research. "Pancakes for Parkinson's," an all-you-can- eat pancake breakfast, will be held on Friday, April 30, 2010, from 7 a.m.-7 p.m. at Denny's restaurants in western and central New York. All donations to the free pancake breakfast will support MJFF.
- Landmark five-year $40-million global research study aims to identify biomarkers of Parkinson's disease progression, critical tools for drug development - NEW YORK, Sept. 28 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI) (www.michaeljfox.org/PPMI), the first-ever large- scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
NEW YORK, April 23 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced more than $3 million in previously unannounced awards ending the first quarter of 2010. The funded projects complement the Foundation's annually occurring Pipeline Programs and Critical Challenges in Parkinson's Disease initiatives, which aim to accelerate PD therapeutic development. Many of the 17 different projects announced today provide additional funding to advance promising avenues of PD therapeutic development. John Sinclair, Ph.D., of the University of Cambridge is continuing his work to investigate the possible use of viral RNA to protect the neurons that die in Parkinson's disease. Dr. Sinclair first received an award in 2008, under the Foundation's Rapid Respon...
NEW YORK, July 1 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research has awarded research teams at eight biotech and pharmaceutical companies a total of $3 million for pre-clinical Parkinson's drug development projects. Funded investigations aim to push forward approaches that could slow or stop progression of the disease, alleviate symptoms or refine existing therapies. MJFF welcomes industry researchers to apply for funding under any of its programs and has awarded approximately $41 million to biotech and pharmaceutical companies to date. To specifically encourage industry proposals, the Foundation in 2006 began designating $5 million in annual funding exclusively for industry researchers through its Therapeutics Development Initiative (TDI). TDI is one e...
-Window display raises awareness of a disease that affects one million Americans- NEW YORK, July 6 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
NEW YORK, June 22 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced $4.6 million in awards to support two promising studies of neurotrophic factor therapies for Parkinson's disease. The projects, funded under a directed LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) initiative, bring together leading investigators to build on the knowledge and experience gained from previous trials of neurotrophic factors to help speed this avenue of research toward better treatments for people living with PD. Neurotrophic factors (also known as trophic factors or growth factors) are specialized proteins that protect and nourish neurons in the brain, including the dopamine neurons that die in Parkinson's disease. Preclinical studies and several...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company